TERM ID="NYU_TERM_1" STRING="CTLA-4" FREQUENCY=1 START=923 END=929 LEMMA="CYTOTOXIC LEUKOCYTE ANTIGEN 4" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_2" STRING="Immune checkpoint blockade" FREQUENCY=1 START=0 END=26 LEMMA="IMMUNE CHECKPOINT BLOCKADE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="PD-1" FREQUENCY=1 START=882 END=886 LEMMA="PROGRAMMED CELL DEATH 1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="RCC" FREQUENCY=2 START=141 END=144 LEMMA="RENAL CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_5" STRING="RCC" FREQUENCY=2 START=1537 END=1540 LEMMA="RENAL CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_6" STRING="RCC cell growth" FREQUENCY=1 START=491 END=506 LEMMA="RCC CELL GROWTH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="RCC patients" FREQUENCY=1 START=1348 END=1360 LEMMA="RCC PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Renal cell carcinoma" FREQUENCY=2 START=119 END=139 LEMMA="RENAL CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_9" STRING="Renal cell carcinoma" FREQUENCY=2 START=119 END=139 LEMMA="RENAL CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_10" STRING="angiogenesis" FREQUENCY=1 START=527 END=539 LEMMA="ANGIOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="anti-tumor effects" FREQUENCY=1 START=1022 END=1040 LEMMA="ANTI-TUMOR EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="called checkpoint inhibitors" FREQUENCY=1 START=797 END=825 LEMMA="CALLED CHECKPOINT INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="checkpoint blockade" FREQUENCY=1 START=1514 END=1533 LEMMA="CHECKPOINT BLOCKADE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="checkpoint inhibitors" FREQUENCY=2 START=1130 END=1151 LEMMA="CHECKPOINT INHIBITOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="checkpoint inhibitors" FREQUENCY=2 START=1195 END=1216 LEMMA="CHECKPOINT INHIBITOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_16" STRING="clinical trials" FREQUENCY=1 START=103 END=118 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="clinical trials Renal cell carcinoma" FREQUENCY=1 START=103 END=139 LEMMA="RENAL CELL CARCINOMA CLINICAL TRIAL" LEMMA_FREQUENCY=1 HEAD_TERM="Renal cell carcinoma" HEAD_LEMMA="RENAL CELL CARCINOMA"
TERM ID="NYU_TERM_18" STRING="cytotoxic leukocyte" FREQUENCY=1 START=892 END=911 LEMMA="CYTOTOXIC LEUKOCYTE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="cytotoxic leukocyte antigen 4" FREQUENCY=1 START=892 END=921 LEMMA="CYTOTOXIC LEUKOCYTE ANTIGEN 4" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="genitourinary malignancy" FREQUENCY=1 START=158 END=182 LEMMA="GENITOURINARY MALIGNANCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="immunotherapeutic agents" FREQUENCY=1 START=772 END=796 LEMMA="IMMUNOTHERAPEUTIC AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="immunotherapeutic agents called checkpoint inhibitors" FREQUENCY=1 START=772 END=825 LEMMA="CALLED CHECKPOINT INHIBITOR IMMUNOTHERAPEUTIC AGENT" LEMMA_FREQUENCY=1 HEAD_TERM="called checkpoint inhibitors" HEAD_LEMMA="CALLED CHECKPOINT INHIBITOR"
TERM ID="NYU_TERM_23" STRING="immunotherapy" FREQUENCY=1 START=665 END=678 LEMMA="IMMUNOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="including RCC" FREQUENCY=1 START=1067 END=1080 LEMMA="INCLUDING RCC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="metastatic" FREQUENCY=1 START=189 END=199 LEMMA="METASTATIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="metastatic RCC" FREQUENCY=2 START=307 END=321 LEMMA="METASTATIC RCC" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_27" STRING="metastatic RCC" FREQUENCY=2 START=456 END=470 LEMMA="METASTATIC RCC" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_28" STRING="non-specific immunotherapy" FREQUENCY=1 START=246 END=272 LEMMA="NON-SPECIFIC IMMUNOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="novel immunotherapeutic strategy" FREQUENCY=1 START=32 END=64 LEMMA="NOVEL IMMUNOTHERAPEUTIC STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="novel immunotherapeutic strategy for renal cell carcinoma" FREQUENCY=1 START=32 END=89 LEMMA="RENAL CELL CARCINOMA NOVEL IMMUNOTHERAPEUTIC STRATEGY" LEMMA_FREQUENCY=1 HEAD_TERM="novel immunotherapeutic strategy" HEAD_LEMMA="NOVEL IMMUNOTHERAPEUTIC STRATEGY"
TERM ID="NYU_TERM_31" STRING="programmed cell death 1" FREQUENCY=1 START=857 END=880 LEMMA="PROGRAMMED CELL DEATH 1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="proliferation" FREQUENCY=1 START=508 END=521 LEMMA="PROLIFERATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="regulatory T cells" FREQUENCY=1 START=943 END=961 LEMMA="REGULATORY T CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="renal cell carcinoma" FREQUENCY=1 START=69 END=89 LEMMA="RENAL CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_35" STRING="response enhancement" FREQUENCY=1 START=981 END=1001 LEMMA="RESPONSE ENHANCEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="side-effects" FREQUENCY=1 START=370 END=382 LEMMA="SIDE-EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="targeting agents" FREQUENCY=1 START=1255 END=1271 LEMMA="TARGETING AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="term responders" FREQUENCY=1 START=620 END=635 LEMMA="TERM RESPONDER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="therapy drugs" FREQUENCY=1 START=414 END=427 LEMMA="THERAPY DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="vascular endothelial growth factor" FREQUENCY=1 START=1220 END=1254 LEMMA="VASCULAR ENDOTHELIAL GROWTH FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="vascular endothelial growth factor targeting agents" FREQUENCY=1 START=1220 END=1271 LEMMA="TARGETING AGENT VASCULAR ENDOTHELIAL GROWTH FACTOR" LEMMA_FREQUENCY=1 HEAD_TERM="targeting agents" HEAD_LEMMA="TARGETING AGENT"
